Topic Paragraphs
Donate COVID-19 Plasma
If you have fully recovered from COVID-19, you may be able to help patients currently fighting the infection by donating your plasma.
Featured Topics
New Era of Smarter Food Safety
A new approach to food safety that recognizes and builds on the progress made in the past but looks towards what processes and tools will be needed for the future.
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
Recent Press Announcements
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Nov 09
Lohxa LLC Issues Voluntary Nationwide Recall of Chlorhexidine Gluconate Oral Rinse USP, 0.12% Due to Microbial Contamination
Drugs
Nov 06
Tanimura & Antle Voluntary Recalls Packaged Single Head Romaine Lettuce Due to Potential E. Coli 0157:H7 Contamination
Food & Beverages
Nov 02
Nostrum Laboratories, Inc. Issues Voluntary Nationwide Recall of Metformin HCl Extended Release Tablets, USP 750 mg, Due to N-Nitrosodimethylamine (NDMA) Content Above the Acceptable Daily Intake (ADI) Limit
Drugs
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
The FDA’s Vaccines and Related Biological Products Advisory Committee and its Role in Advising the Agency on COVID-19 Vaccines
This week, the FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) is meeting to discuss vaccines to prevent COVID-19.
FDA’s Technology Modernization Action Plan Accelerates the Path to Enhancing and Promoting “People First” Public Health
FDA’s TMAP is the blueprint for modernizing our IT systems.
A Culture of Responsibility: Laboratory Safety at the FDA
A cornerstone of the U.S. Food and Drug Administration’s scientific work is to ensure that we operate our laboratories in a safe and secure manner.
Recently Published Guidances
Nov 10
Draft Guidance for Industry: Voluntary Disclosure of Sesame as an Allergen
Food & Beverages
Nov 10
Regulatory Considerations for Microneedling Products
Medical Devices
Nov 09
Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs Guidance for Industry
Drugs